Key facts
- This page summarizes Frost Phillip MD Et al's Form 4 filing for Fluent, Inc. (FLNT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 Dec 2024, 14:58.
Frost Phillip MD Et al - 09 Dec 2024 Form 4 Insider Report for Fluent, Inc. (FLNT)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- FLNT
- Reported as of
- 09 Dec 2024
- Net transaction value
- +$324
- SEC form
- 4
- Accepted by SEC
- 11 Dec 2024, 14:58:20 UTC
- Prior SEC filing
- 06 Dec 2024
- Next SEC filing
- 11 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Phillip Frost, M.D., Individually
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Frost Phillip MD Et al filed Form 4 for Fluent, Inc. (FLNT) on 11 Dec 2024.
Change
- Previous filing in this sequence was filed on 06 Dec 2024.
- Current net transaction value: +$324.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FLNT
transaction
Common Stock
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $324
- Shares
- +647,892
- Change %
- +17%
- Price
- $0.000500
- Shares after
- 4,378,056
- Date
- 09 Dec 2024
- Ownership
- Held by Frost Gamma Investments Trust
- Footnotes
- F1
FLNT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 8,334
- Date
- 09 Dec 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FLNT
transaction
Derivative
Pre-Funded Warrant
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $0
- Shares
- -647,892
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 09 Dec 2024
- Ownership
- Held by Frost Gamma Investments Trust
- Underlying class
- Common Stock
- Underlying amount
- 647,892
- Exercise price
- $0.000500
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Footnote F2
The Pre-Funded Warrants were immediately exercisable when issued. The Pre-Funded Warrants were exercised on December 9, 2024.
Footnote F3
The Pre-Funded Warrants will terminate when exercised in full.